Why This Menopause Expert Turned Down Trump’s Rose Garden Photo Op

On Monday, President Donald Trump and First Lady Melania Trump presided over a bizarre ceremony in the Rose Garden where she made rare public remarks and he signed an executive order, “Advancing Women’s Health to Improve Outcomes in All Phases of Life.”

Never mind that his executive order has the same primary objectives as one signed by President Joe Biden in 2024—namely, increased research in and knowledge about diseases and conditions that affect women uniquely or disproportionately. Both executive orders make explicit the need to focus on menopause, midlife and aging, with stated priorities such as Alzheimer’s Disease, cardiovascular and heart disease, stroke and osteoporosis.

The biggest difference between the two is that Biden’s tied dollar amounts to these objectives: Though the $12 billion he directed Congress to allocate never materialized, hundreds of millions were activated across several federal agencies.

Alas, that executive order is now officially replaced with the current one.

As much as I want to mean it when I say, This agenda must transcend partisanship, and I want to show up for the millions of women who deserve these hard-won milestones—it was way too large a leap to be in the room where this executive order happened.

Yes, I was invited to the Rose Garden. Yes, I declined.

Why Women Need a Hormonal Bill of Rights

For too long, midlife symptoms of women have been minimized; our concerns dismissed, our suffering normalized and our voices overlooked. We reject the notion that hormonal decline is simply something to endure.

Everyone has the right to connection, support, shared knowledge, honest conversation free from shame and community in search of quality of life.

To ask questions.
To demand answers.
To require equal research.
To expect better healthcare.
To defy patriarchal control.
To hormonally radicalize the world.

Restricting Mifepristone Access Could Empower Abusers

The 5th U.S. Circuit Court of Appeals heard arguments on Sept. 9 in Louisiana v. FDA, one of three cases threatening nationwide access to mifepristone, the medication used in the majority of abortions in the United States. 

While its stakes center on access to mifepristone generally, survivors of intimate partner violence (IPV) may be among the hardest hit by a national restriction on the abortion care drug.  

Already living under extreme, sometimes life-threatening, circumstances, survivors have vanishingly few options to care for themselves in the event of a pregnancy. Telehealth treatment and access to mifepristone by mail have been one of the few reprieves offered thus far, and their restriction could pose grave consequences to survivors nationwide.

You Deserve Better Menopause Care. Here’s How to Demand It.

“As women we have become way too comfortable with suffering,” said menopause expert Dr. Sharon Malone, MD, at a New York City book launch event for Jennifer Weiss-Wolf’s When in Menopause. “Menopause is just the last on the long train of suffering stops we’ve had.”

Weiss-Wolf’s new book makes the case for changing that, from demanding better care in the doctor’s office to fighting for policies that take women’s health seriously. As she put it during the conversation: “We’re saying we demand to be seen. We demand to be heard.”

In the following excerpt, Weiss-Wolf offers practical guidance for becoming your own best champion and receiving informed, respectful midlife healthcare.

When in Menopause: A User’s Manual and Citizen’s Guide is out Tuesday, Oct. 6, from Sheldon Press.

Antiabortion Politics Blocks Research on Fibroids, Endometriosis and Breast Cancer. The Media Is Finally Paying Attention.

Mifepristone is known as the abortion pill, but it has other uses most Americans have never heard about. For more than three decades, scientists have known this medication could do far more than end a pregnancy. Research shows mifepristone and a similar drug ulipristal acetate (sold under the brand name ella) can shrink fibroids, treat endometriosis and may treat and even prevent breast cancer.

Despite this huge potential to improve women’s health and well-being, abortion opponents have obstructed research into these treatments for decades, fearing anything that could make mifepristone more available would weaken their fight against abortion.

The burden of this obstruction has fallen on women, left to suffer from years of painful fibroids and endometriosis, heavy bleeding and reduced fertility, or death from aggressive forms of breast cancer, while research that could help sits on the shelf.

For years, the fight to unlock mifepristone’s lifesaving potential was a story only feminist media would tell, but mainstream media is finally catching up.

Activists Have Fought for Disability Justice. So-Called ‘Sickfluencers’ Still Face Medical Sexism.

Mainstream legacy media in the U.K. has found a new target: young disabled women.

Last week, Telegraph editor Poppy Coburn published “How having a disability became cool,” arguing so-called “sickfluencers” are “turning chronic illness into a lifestyle trend.” Just a month earlier, Times of London columnist Kathleen Stock suggested the disproportionate number of Gen Z women diagnosed with what she called “vague syndromes” may be experiencing “social contagion.” Both pieces cast suspicion on young disabled women and the ways they discuss chronic illness and use mobility aids, reflecting a growing strain of far-right rhetoric that treats disabled women’s accounts of their own bodies with suspicion.

Half the Country, a Fraction of the Research

For decades, Democratic and Republican administrations alike presided over a medical research system that routinely excluded women. The result? Modern medicine was built on incomplete science—and women are still paying the price. 

It wasn’t until the NIH Revitalization Act of 1993 that federally funded clinical trials were required to include women. Yet changing who participates in research does not rewrite decades of medical knowledge overnight. By then, physicians had already been trained using male-centered evidence, diagnostic standards had been established, and countless drugs had already been dosed using evidence derived solely from men.  

In 2025, the Trump administration has proposed cutting the NIH’s budget by roughly 43 percent (equivalent to $20 billion per year). Its broader HHS budget proposal called for eliminating or consolidating several programs supporting family planning and maternal and child health. Federal agencies also came under pressure to scrutinize or reject grant proposals containing terms such as women, leading to paused or cancelled fellowships and research on conditions such as uterine fibroids and pregnancy. 

There are signs, however, that Congress may finally be beginning to treat women’s health across the lifespan as a serious policy issue.

On Sept. 16, the Senate Special Committee on Aging will hold Congress’ first-ever hearing devoted to menopause. Led by ranking member Sen. Kirsten Gillibrand (D-N.Y.), “Half the Country, Zero Hearings: Meeting the Moment to End the Menopause Care Gap in America” will examine the nation’s lack of menopause research, informed medical care and provider training—and make the case for greater federal investment.

The hearing represents an overdue step forward. But women’s health cannot remain vulnerable to political cycles. Regardless of which party holds power, it must become a permanent priority within American policy and medicine.

‘It’s About Who Gets to Decide’: Massachusetts Will No Longer Impose a Gestational Limit on Access to Abortion Care

Gov. Maura Healey signed the Prioritizing Patient Access to Care Act into law last month, making Massachusetts the 10th state, together with Washington, D.C., that does not impose a gestational limit on access to abortion care.

In so doing, Healey stressed the “heartbreaking stories” she heard “from women and families who were preparing to welcome a healthy baby into their family, only to receive devastating news later in their pregnancy. Instead of being able to rely on the doctors they knew and trusted at home, they were forced to travel hundreds of miles and pay out of their pockets while navigating unimaginable grief.”

I recently had the privilege of talking with Kate Dineen who shared her tragic experience of being denied abortion care in Massachusetts because of the state’s “24-week ban with very difficult to access exceptions.” 

Here is her story.

Dispatches From Daisy Chain: Olivia Rodrigo’s Feminist Festival Brought Together Music, Reproductive Freedom and the Power of Women

On Saturday, Aug. 29, more than 45,000 music fans traveled to Irvine, Calif., for the first-ever Daisy Chain Fields music festival, organized and headlined by Olivia Rodrigo, where 100 percent of the proceeds went to organizations supporting women and girls. Under the sweltering SoCal sun, an all-women lineup—including sets from Mitski, Doechii, Garbage, Chappell Roan and others—fundraised for 10 nonprofits: Baby2Baby, Black Mamas Matter Alliance, Center for Reproductive Rights, FreeFrom, Jhpiego, Johns Hopkins Center for Indigenous Health, National Domestic Workers Alliance, National Institute for Reproductive Health National Women’s Law Center and Planned Parenthood.

The all-day festival, inspired by Sarah McLachlan’s Lilith Fair of the 1990s, raised $10 million in ticket sales. Then, during her set at the end of the day, Rodrigo announced (to massive applause) that Melinda French Gates was matching every dollar raised—bringing the festival’s total donation to $20 million for diverse nonprofits supporting sexual and reproductive health, children in need, Black mothers, gender-based violence survivors, Indigenous communities and more.

I was lucky enough to go to Daisy Chain Fields and cover the festival for Ms. In the “Daisy Chain Reaction Village,” I spoke with several of the organizations that will receive Daisy Chain Fields funds.

“We wanted to come to the festival because we feel really passionately about connecting with new audiences on the issue of reproductive rights, particularly younger audiences who may not be as aware or knowledgeable about the national and international state of reproductive rights and bodily autonomy,” said Esme Lowe from the Center for Reproductive Rights. “It’s just super exciting because we’re engaging with people we might not [otherwise] even get to talk to.”

In line outside the Daisy Chain Reaction Village, sisters Madison and Mackenzie Wong said they were excited to attend the festival in their home city of Irvine, and happy to see a lot of younger fans of Olivia Rodrigo there to learn about the causes Daisy Chain Fields was supporting. 

“I think it’s important for big artists who have a platform to use their voice,” Mackenzie said. “They have so much influence anyway, so no matter what they say, it’s going to have a broader impact.”

Rest in Power, Dolly Parton: Feminist Country Icon, Advocate for Women and Children, Philanthropist and Gifted Songwriter

Dolly Parton understood the power of being underestimated. Beneath the rhinestones, towering blond hair and self-deprecating jokes was a gifted songwriter, a shrewd businesswoman and a philanthropist whose work transformed the lives of millions of children and families.

Parton left behind a body of work that stretches far beyond the songs and films that made her one of the most beloved performers in American life. She sang about the dignity of working women. She placed hundreds of millions of books in the hands of children. She supported healthcare, disaster relief and lifesaving medical research. And she repeatedly used her enormous cultural influence to affirm the humanity of people who were too often marginalized, including Black and LGBTQ+ Americans.

Parton’s concern for women and children was expressed not only through her art, but in what she did with the wealth and influence her art created. We heard her legacy in the songs that made working women feel seen. We saw it in the books delivered to children, the families supported after disaster and the medical research that saved lives.

May Dolly Parton rest in power. May her legacy live on in every child who discovers a new world inside a book, every woman who demands dignity in the workplace and every person who chooses compassion when indifference would be easier.